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Original Article
Negative predictive value of mammography and sonography in
mastalgia with negative physical findings

Imrana Masroor, Shaista Afzal, Saima Sakhawat, Nadir Khan, Mirza Amanullah Beg, Darakhshan Kawal
Department of Radiology, Aga Khan University Hospital, Karachi.

Abstract

Objective: To determine the negative predictive value of mammography and sonography in patients with focal/
diffuse breast pain with negative physical examination of the breasts.
Methods: A descriptive study, conducted at Radiology Department of Aga Khan University Hospital from 2006-2007 for
a period of 2 years. A total of 207 women were referred for mammography and sonography because of focal or diffuse
breast pain. Complete follow-up was available only in 55 patients. The outcome or gold standard was mammograms or
ultrasound after an average follow-up period of 18 months with negative/ benign findings or histopathology of the
suspicious lesion or imaging which was the gold standard to determine the negative predictive value.
Results: Out of 55 patients, 17 (31%) had negative findings, benign findings were reported in 34 patients (62%),
and 4 (7%) patients were subjected to mammographically guided breast biopsy. All the biopsies were done on
the basis of abnormal findings on mammograms. All of the 4 patients had no evidence of cancer on subsequent
histopathology. The negative predictive value of mammography and ultrasound in women with focal or diffuse
breast pain was 100%.
Conclusion: Breast imaging using mammography and/or sonography in women who present with local or
diffuse breast pain is of significant value, to reassure the patient as well as the clinician. However if imaging
findings are suggestive of pathology a biopsy should not be delayed (JPMA 59:598; 2009).

Introduction

Breast imaging is a valuable tool in the investigation
of symptomatic breast disease. Breast mass and breast pain
are two common complaints1 responsible for a woman
consulting a health care provider. Established management
of palpable breast lesion is triple assessment which includes
physical examination, mammography, and percutaneous
biopsy.2,3
Breast pain, also known as mastodynia or mastalgia,
is a common condition.4 Clinically mastalgia is divided into
two types, cyclical mastalgia and non cyclical mastalgia.5 In
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healthy women self referred to breast screening clinics 69%
reported pain severe enough to interfere with their daily
activities.6 Breast pain is a frequent symptom for which
women seek medical attention7 and causes significant
patient anxiety. In women presenting with breast pain, the
reported prevalence of breast cancer ranges from 0%3.2%.8-12

A large number of patients with breast symptoms are
referred for mammography and sonography. The utility of
mammography and sonography in the evaluation of a
palpable breast lump is well established, with negative
predictive values ranging from 99.8% -100%.13,14
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However the value of mammography and
sonography in evaluation of focal/ diffuse breast pain is not
well established. This study was conducted to determine the
negative predictive value of mammography and sonography
in evaluation of patients with focal or diffuse breast pain
without a palpable mass.

Patients and Methods

It was a descriptive study conducted at the
Radiology department of Aga Khan University Hospital.
The duration of study was from January 2006 to December
2007. During this period, 207 patients were referred for
mammography and sonography for focal/diffuse breast
pain. Our inclusion criteria were patients with focal/diffuse
breast pain without a palpable lump, patients with both
mammograms and whole breast sonograms, those with
complete medical records and a follow-up of at least 18
months with mammograms or sonograms, or with
histopathology of suspicious area seen on imaging.
The exclusion criteria was all patients with
incomplete records, patient with history of breast cancer or
with family history of breast cancer.
All patients underwent mammography on
Mammomat NOVA 3000 (Siemens). The mammograms
were double read by 2 radiologists. All the patients were
then subjected to whole breast ultrasound. Ultrasound was
done by a 7.5 MHz probe on either Nemio/ Xario ultrasound
machines. Both mammograms and breast ultrasound were
reported by radiologists with at least 3 years experience in
mammography and sonomammography. The gold standard
was taken as final Breast Imaging Reporting and Data
System (BIRADS) categorization after all workup or
histopathology. Final BIRADS categorization was done
after an average follow up of 18 months with mammograms
or ultrasound. The patients with suspicious findings on
imaging were subjected to imaging guided biopsy of
suspicious area followed by histopathology.
The data was analyzed using SPSS 16.

Results

The mean age of patients in this study was 44.5 ± 4.6
years (range 34-63 years). All the patients presented with
unilateral or bilateral breast pain. Only in 5 patients the pain
was, focal and the rest had diffuse non-specific pain. Most
of the patient were premenopausal and had no past history
or family history of breast cancer. Out of 207 patients

complete medical records of only 55 patients were
available. Rest of the patients did not have follow up, so
were excluded from the study. The final BIRADS category
of 55 patients is given in Table-1. The further categorization
of mammographic and sonographic (BIRADS) lexicon is
given in Table-2.
Our of 55 patients 17 had negative findings on
mammography and whole breast ultrasound and were
categorized as BIRADS category 1 (Table-1).
Table-1.
Total n= 55

BI- RADS (%)

17
34
4

Category 1 (31%)
Category 2 (62%)
Category 4 (7%)

Thirty four patients were categorized as BIRADS
category 2.

Out of these 34 patients 10 were categorized as
BIRADS 2 on mammograms. Mammograms had shown
either benign type of calcifications or one or two benign
appearing 0.5x 0.5 mm nodules in either breast. Ultrasound
showed benign findings in 26 patients either showing a
single or a few simple cysts or presence of short segment
duct ectasia (Table-2). All these patients had a repeat
mammogram or ultrasound after an average follow-up
period of 18 months, and the finding remained stable or
regressed.

All patients categorized as BIRADS 1 or 2 were
taken as true negatives.
A total of four patients were categorized as category
4 on the mammograms due to presence of parenchymal
asymmetry or abnormal mammographic density not
forming a definite nodule. All these four patients were
subjected to mammographically guided biopsy; one patient
had focal atypical ductal hyperplasia. Atypical ductal
hyperplasia and ductal carcinoma in situ are pathologically
similar and may coexist, therefore the patient underwent
open surgical biopsy to obtain a free margin. This one case
was taken as true positive. One patient had florid ductal
hyperplasia, and rest of the two patients had simple ductal
hyperplasia, and reactive lymph node hyperplasia. All of
these findings are suggestive of benign results. All three of
them were taken as false positive. There were no false

Table-2.
Mammography (n=17)
Birads 1 (17)
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US (n=17)

Mammography (n=34)

US(n=34)

Mammography ( n=4)

Birads 1 (17)

Birads 2 (10)
Birads 0 (24)

Birads 1 (8)
Birads 2 (26)

Birads 4 (4)
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negative patients. The negative predictive value of
combined mammography and ultrasonography in patient
with focal/diffuse breast pain in our study was 100%.

Discussion

Both mammography and ultrasound showed normal
breast parenchyma in 31% of patients. Imaging showed
benign findings in 62% of patients, more importantly no
cancer was detected, even in those patients in which the
mammography reported suspicious findings. It is not
known how often breast cancer is manifested as breast pain
alone, but it appears to be infrequent. Preece et al15
reported in their study comprising of 240 women with
operable breast cancer, only 7% had pain alone. However,
the discovery of cancer in these patients may have been
incidental and not directly related to the primary symptom
of isolated breast pain.

One patient underwent biopsy of suspicious lesion as
seen on mammogram (True positive), had atypical ductal
hyperplasia (ADH), it is known that a histopathologic result
of ADH after an image guided core needle biopsy of a breast
lesion may underestimate the presence of ductal carcinoma
in situ (DCIS) or invasive carcinoma as both ADH and
DCIS are pathologically similar and can co exist.. The
surgeon reexcised the area to obtain a clear margin free of
atypical hyperplasia changes. This was important as in
literature, the reported rates of upgrade of atypical
hyperplasia after 14-guage needle biopsy is 33%.16 The
tissue was removed before the development of overt
malignancy thus reducing morbidity and mortality
associated with breast cancer. In three patients (False
positives) the mammography showed subtle parenchymal
asymmetry. In 2 of these patients it persisted on cone
compressed view, and in one patients there was a small
cluster of punctuate micro calcifications. All 3 patients had
imaging findings which were not corresponding to area of
pain, but still they were subjected to biopsy to rule out
possibility of malignancy, all three of them had negative
histopathology results. There were no false negative results.
In a study conducted by Duijm et al10 which was an
observational follow up study, they compared 987 women
referred for breast imaging because of pain alone with 987
asymptomatic
women
referred
for
screening
mammography. Breast imaging consisted of diagnostic
mammography and possible sonography in patients older
than 25 years; they included patients with focal and diffuse
breast pain. They found that the prevalence of breast cancer
in their study group was 0.8% similar to control group
0.7%, suggesting that pain is not associated with increase in
breast cancer risk. However, these results must be
interpreted with caution because of small number of cancers
detected in Duijm study. No cancers were detected in our
600

study. This can be due to the small sample size of 55
patients, which is one of the limitations of our study.

The negative predictive value of ultrasound in
focal/diffuse pain in our study is 100% this is similar to a
study conducted by Tumyan et al,17 who reported a negative
predictive value of 100%. The only difference between
Lusine’s study and our study was that he had included only
patients with focal breast pain.

In a study conducted by Soo et al13 the negative
predictive value of mammography with sonography was
reported as 99.8%. In this study all patients presented with
palpable breast lesions, whereas, in our study all patients
had negative physical examination of breasts and presented
with either focal or diffuse breast pain.
There are a few other limitations of our study that an
average follow up of only 18 months is available. We are not
sure that this is long enough to detect a slow growing cancer. If
a longer follow up was available cancers may have been
detected.
The other limitation is selection bias, as all those
patients with palpable masses were excluded from the
study because it is well established that patients with
palpable findings warrant diagnostic imaging to exclude
malignancy. Another limitation was referral bias as general
practitioners do not always refer patients who present with
breast pain to a radiologist. Several women on the basis of
negative physical examination must have been reassured
by the general practitioner and had not under gone any
imaging.

Conclusion

The combined value of mammography and
sonography in focal/diffuse breast pain without a palpable
breast mass is 100%. These imaging modalities can be
reassuring to the patients as well as the referring clinician if
follow-up is planned and physical examination is negative.
However if the imaging findings are suspicious a biopsy
should not be delayed.
1.
2.
3.

4.
5.
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